Publications by authors named "Suhail Khadra"
Article Synopsis
- - Patients with heart failure and preserved ejection fraction (HFpEF) who have an ejection fraction of 60% or higher have limited treatment options, making the study of new treatments important.
- - The EMBARK-HFpEF trial tested a drug called mavacamten on 30 patients with symptomatic HFpEF over 26 weeks, measuring outcomes such as NTproBNP and troponin levels to evaluate efficacy and safety.
- - Results showed significant reductions in NTproBNP and troponin levels, indicating potential benefits of mavacamten for these patients, although biomarker levels returned toward baseline after the drug was stopped.
Objective: Cardiac troponin elevation has been shown to be associated with adverse outcomes after percutaneous coronary intervention (PCI) for various subgroups of coronary artery disease. We sought to determine the prognostic significance of cardiac troponin I (cTnI) in patients with non-ST-elevation acute coronary syndromes (NSTE-ACS) treated with PCI.
Methods: The study consisted of 760 consecutive patients undergoing PCI for NSTE-ACS.
Background: Prior studies have reported conflicting findings regarding racial disparities in long-term cardiovascular outcomes after percutaneous coronary intervention (PCI). Our aim was to compare major adverse cardiac events (MACE) following PCI in black versus non-black patients in a Public Health Service (PHS) setting.
Methods: A cohort of 1,438 consecutive patients undergoing intended PCI at a large public teaching hospital between April 2002 and September 2006 were followed for the development of MACE, defined as a composite of death, myocardial infarction (MI) and urgent target vessel revascularization.
Introduction: Bacillus Cereus endocarditis is a rare condition which has been implicated in intravenous drug users, and in patients with prosthetic heart valves. We report a rare case of Bacillus Cereus infecting a permanent pacing wire.
Case Presentation: A 69 year old female with a permanent pacemaker presented with rigors, sweats and weight loss.
Perioperative myocardial infarction in a patient with metabolic syndrome.
J Diabetes Complications
December 2007
We report on the case of a 19-year-old Hispanic male with metabolic syndrome who developed a myocardial infarction after an uneventful appendectomy. To our knowledge, this is the first published report of a young adult with metabolic syndrome suffering a major cardiac event after a simple abdominal surgical procedure. It raises the question as to how to prevent such complications in the future.
View Article and Find Full Text PDF